VERU INC. Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31)
VERU INC. (VERU) reported Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) of $3.00 million for the 3-month period ending 2012-12-31, per its 10-Q filed 2013-01-30.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount · last filed 2013-01-30
- VERU INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2012-12-31 was $3.00M.
| Period end | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 22 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 23 month |
|---|---|---|---|---|
| 2012-12-31 | $3.00M 10-Q · filed 2013-01-30 | |||
| 2010-12-31 | $3.00M 10-Q · filed 2012-07-31 | |||
| 2009-12-31 | $2.00M 10-Q · filed 2012-07-31 | |||
| 2007-01-17 | $1.00M 10-Q · filed 2013-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |